Clinical trials
Recruiting Uterine Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 2 |
| AstraZeneca | 2 |
| M.D. Anderson Cancer Center | 2 |
| University of Alabama at Birmingham | 2 |
| Washington University School of Medicine | 2 |
| City of Hope Medical Center | 1 |
| Dana-Farber Cancer Institute | 1 |
| Denise Fabian | 1 |
| Duke University | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Neoplasms | 28 |
| Ovarian Neoplasms | 11 |
| Uterine Cervical Neoplasms | 10 |
| Endometrial Neoplasms | 9 |
| Breast Neoplasms | 6 |
| Vulvar Neoplasms | 4 |
| Fallopian Tube Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
| Vaginal Neoplasms | 3 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.